Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jay R. Luly currently holds 858,026 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay R. Luly has been a net seller of ENTA stock. They have purchased $0 and sold $14.5M worth of shares.
Jay R. Luly's most recent insider trade was on Dec 5, 2025, when they sold 4,743 shares at $14.23 per share.
Jay R. Luly serves as Executive at ENANTA PHARMACEUTICALS INC (ENTA). They have executed 88 insider transactions totaling $14.5M over their tenure at the company.
Jay R. Luly holds the position of Executive at ENANTA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jay R. Luly has shown a selling trading pattern, with $0 in total purchases and $14.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jay R. Luly was on Feb 12, 2019, when they sold $1.8M worth of ENTA shares. This transaction involved 20,730 shares at $88.88 per share.
Jay R. Luly currently owns 858,026 shares of ENANTA PHARMACEUTICALS INC (ENTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jay R. Luly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jay R. Luly has 88 Form 4 filings on record as an insider at ENANTA PHARMACEUTICALS INC.
Set alerts for Jay R. Luly and 40,000+ other insiders.